Host-Directed FDA-Approved Drugs with Antiviral Activity against SARS-CoV-2 Identified by Hierarchical In Silico/In Vitro Screening Methods

The unprecedent situation generated by the COVID-19 global emergency has prompted us to actively work to fight against this pandemic by searching for repurposable agents among FDA approved drugs to shed light into immediate opportunities for the treatment of COVID-19 patients. In the attempt to proc...

Descripción completa

Detalles Bibliográficos
Autores principales: Ginex, Tiziana, Garaigorta, Urtzi, Ramírez, David, Castro, Victoria, Nozal, Vanesa, Maestro, Inés, García-Cárceles, Javier, Campillo, Nuria E., Martinez, Ana, Gastaminza, Pablo, Gil, Carmen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067418/
https://www.ncbi.nlm.nih.gov/pubmed/33917313
http://dx.doi.org/10.3390/ph14040332

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067418/
https://www.ncbi.nlm.nih.gov/pubmed/33917313
http://dx.doi.org/10.3390/ph14040332

Ejemplares similares